Mimedx (MDXG) Total Liabilities (2010 - 2026)

Mimedx has disclosed Total Liabilities across 17 years of filings, most recently posting $65.7 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $65.7 million, down 2.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.7 million (down 2.81% YoY), and the FY2025 annual result was $86.1 million, up 21.6% from the prior year.
• Total Liabilities came in at $65.7 million for Q1 2026 at Mimedx, down from $86.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $99.8 million in Q3 2022 to a low of $62.1 million in Q2 2024.
• The 5-year median for Total Liabilities is $86.1 million (2025), against an average of $82.0 million.
• Across the five-year window, Total Liabilities slumped 35.64% in 2024 and rose 27.29% in 2025, its largest moves.
• Mimedx's Total Liabilities stood at $96.9 million in 2022, then decreased by 0.61% to $96.3 million in 2023, then retreated by 26.49% to $70.8 million in 2024, then grew by 21.6% to $86.1 million in 2025, then dropped by 23.65% to $65.7 million in 2026.
• The last three Total Liabilities figures came in at $65.7 million (Q1 2026), $86.1 million (Q4 2025), and $80.0 million (Q3 2025), per Business Quant data.